Octreotide chloride

氯化奥曲肽

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameOctreotide chloride
Drug Alias Name奥瑞肽Octreotide sc depotOctreotide controlled releaseOctreotide chloride controlled releaseOctreotidum +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsGastroenteropancreatic neuroendocrine tumorAscitesDilatation, Pathologic +[33] 
Global Approved IndicationsAcromegaly
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/06/30
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCamurus Ab
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterNational Center For Advancing Translational SciencesCamurus Ab
Inactive CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979AdventHealth Translational Research InstituteUniversity Of Liverpool +[13] 
Active IndicationsGastroenteropancreatic neuroendocrine tumorAnemiaAngiodysplasia +[9] 
Inactive IndicationsAscitesDilatation, PathologicObesity +[24] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG